Laura Hertel,
Founder & CEO $63,000 - Awarded January 2024 |
Nuapoch, Inc.Oakland, CA
About
Nuapoch, Inc. is a start-up company seeking to develop non-hormonal, effective, and reversible contraceptives by targeting sperm maturation factors. The company was founded in January 2024 by Dr. Laura Hertel and is headquartered in Oakland, California. Our Grant
MCI is supporting Nuapoch’s efforts to determine the three-dimensional structure and key functional domains of an epididymal protein involved in sperm maturation, to enable its targeting with new contraceptive drugs. |
Meet MCI's Grantees & Fellows!
Our grantees and fellows represent some of the finest minds in the male contraception research community from around the world.
At Male Contraceptive Initiative, we prioritize funding research that aligns with our mission of driving male contraception closer to clinical trials. We strategically allocate our resources to support a diverse range of projects, focusing on non-hormonal and reversible methods that have the potential to meet the needs of a broader population. Our goal is to catalyze progress in this field and bring innovative male birth control options to market.
Discover the innovative research being conducted by our grantees and fellows by clicking on the buttons below:
At Male Contraceptive Initiative, we prioritize funding research that aligns with our mission of driving male contraception closer to clinical trials. We strategically allocate our resources to support a diverse range of projects, focusing on non-hormonal and reversible methods that have the potential to meet the needs of a broader population. Our goal is to catalyze progress in this field and bring innovative male birth control options to market.
Discover the innovative research being conducted by our grantees and fellows by clicking on the buttons below:
